Taiwan A genuinely healthy lifestyle can help prevent neurodegenerative disease Charles S.Y. Yang discusses how his background in physics and quantum sensing led to the founding of MagQu, pioneering ultra-sensitive blood biomarker diagnostics for Alzheimer’s and other neurodegenerative diseases. He explains the company’s SQUID-based technology, commercial journey, regulatory ambitions and funding…
MEA A quarter-century after the Human Genome Project revolutionized biology, genomic sequencing has matured from an ambitious scientific frontier into an indispensable clinical reality. Today, molecular insights routinely guide everything from targeted oncology to rare disease diagnostics. Yet, this genomic revolution harbours a profound systemic bias: nearly 90 percent of all…
Taiwan Over the past three decades, Taiwan’s elderly population – defined as individuals aged 65 and older – has expanded by a staggering 152 percent. This demographic shift has introduced complex public health challenges, most notably a sharp rise in cancer incidence. “The epidemiological picture is quite sobering,” notes John Chang,…
Taiwan Biotechnology has long been a strategic priority for Taiwan’s economic development, standing alongside ICT and semiconductors as a key pillar of growth for the island. Driven by a highly educated scientific workforce and competitive development costs, Taiwan is a natural hub for early-phase drug development and initial manufacturing. However, only…
Germany Germany’s Medical Research Act is almost two years old. Writing in the June/July 2026 edition of DIA Global Forum, Thomas Sudhop, Claudia Riedel and Karl Broich of the Federal Institute for Drugs and Medical Devices (BfArM) outline how the Act attempts to revitalise clinical research in Germany, balancing faster procedures…
Taiwan Dr. I-Shu Lee, founder and CEO of Vitae Biomedical, began his career as a postdoctoral researcher before making the uncommon leap from academic laboratory to entrepreneurship in 2019. Built around a proprietary urine-based protein detection technology for early cancer screening, Vitae Biomedical has already achieved commercial traction in Taiwan, partnering…
USA Dr David J. Rawlings is the division head of immunology at Seattle Children’s and director of the Center for Immunity and Immunotherapies at Seattle Children’s Research Institute. An immunologist and rheumatologist working at the forefront of cell engineering, his research focuses on therapies that modulate immune responses across cancer, genetic…
Australia Medicines regulatory agencies face enormous challenges in supporting and maintaining the safety, quality and supply of therapeutic goods in their respective countries and regions. Professor Anthony (Tony) Lawler, head of Australia’s Therapeutic Goods Administration (TGA), took time out from this work to respond to questions regarding the progress that TGA is…
UAE Prof. Fatma Al Jasmi, Professor of Biochemical Genetics at the UAE University’s College of Medicine & Health Science and the UAE’s first biochemical genetics consultant, has spent nearly two decades building a rare and genetic disease infrastructure from the ground up. Prof. Al Jasmi traces that journey – from persuading…
Taiwan Hans Duijf, General Manager of Novo Nordisk Taiwan, has spent his entire 28-year career with the Danish pharmaceutical company, a rare tenure in today’s era of executive mobility. Duijf has led affiliates across several regions before arriving in Taiwan eight months ago. A committed advocate of the company’s triple bottom…
USA Successive American governments have grappled with the need to contain spiraling healthcare costs while sustaining the USA’s well-earned reputation as the number one launch market for breakthrough medical innovations. “The most difficult question of our time in our sector relates to how to fund access to advanced therapies,” explains Marwan…
Europe The European Health Data Space (EHDS) is a landmark regulation designed to unify health data across the EU for both direct patient care and medical research. Writing in the April 2026 edition of DIA’s Global Forum magazine, Tom Brookland, Pascal Hofer, and Didier Pomeranc of Roche explain that while the…
See our Cookie Privacy Policy Here
